Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular SafetyFrederick Cohen, Ryan T. Cirz, Paola Dozzo et al.|ChemMedChem|2019Cited by 76
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaTeresa E. Williams, Daniel Poon, Sharadha Subramanian et al.|ACS Medicinal Chemistry Letters|2015Cited by 54
Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990Christopher M. McBride, Cynthia M. Shafer, Barry H. Levine et al.|Journal of Medicinal Chemistry|2014Cited by 28